Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

The New Age of Fatherhood Can Impact Conception

Rinovum Women's Health
Posted on: 03 Oct 16

It’s long been thought that females were the only ones with a biological clock. However, according to research on conception, the average time it takes to conceive increases five-fold (to two years) for a man who is 40 compared to a man at 25 (with the average of 4.5 months to conception, controlling for the wife’s age at around 25 in both cases).1Lower sperm count and mobility are typically the biggest culprits, so couples concerned about male age factor fertility issues can turn to the Stork® OTC, available over-the-counter and proven to deliver a three times higher concentration of sperm score value within cervical mucus as compared to what might occur during natural intercourse.2

The FDA-cleared over-the-counter Stork OTC uses cervical cap insemination, which includes the collection of sperm in a condom-like sheath, along with an easy-to-use, tampon-like applicator, to deliver the sperm more directly to the cervix in order to quickly bypass the vaginal tract. “This places the sperm as quickly and as close as possible to the opening of the cervix, right where it needs to be to swim to the egg,” explains Dr. Michael J. Pelekanos, Board Certified OB/GYN in Monroeville, PA. “This type of cervical cap insemination has been used effectively in the professional setting, but now it’s readily available to couples at home.”

The Stork OTC is available for purchase at select retailers nationwide and online for the average retail price of $79.99, making it more accessible and less expensive than other first-line options for couples trying to conceive. To learn more about how it works, watch the full video here. For more information and retailer and online availability, as well as pregnancy stories, visit

About The Stork Ib2C, Inc., A Rinovum Women’s Health Company

Rinovum Women's Health is a privately held women's health company dedicated to bringing products into the market that will enhance women's lives and empower them to take charge of their health. The Stork Ib2C, Inc., A Rinovum Women’s Health Company, launched its flagship product, The Stork® OTC, which is a conception device for reproductive health to assist in natural fertility and conception in the privacy of the patient’s home. Rinovum Women's Health aims to support the development of products that are easy-to-use and safe, as well as a more economical way for a couple to address some of these issues. For more information about Rinovum Women's Health, The Stork Ib2C, Inc., and The Stork OTC, visit and .


View source version on

Business Wire

Last updated on: 03/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.